Healthcare -
Biotechnology - NASDAQ - US
$ 313.0
-2.2 %
$ 14.1 B
Market Cap
12.7
P/E
UTHR - TOTAL RECEIVABLES
Total Receivables UTHR - United Therapeutics Corporation
279 M
LAST VALUE
18.47%
2 YEAR CAGR
9.68%
5 YEAR CAGR
8.24%
10 YEAR CAGR